Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by themagicboxon Feb 14, 2020 1:45pm
140 Views
Post# 30692716

RE:RE:RE:RE:If no FE announcement by Sunday

RE:RE:RE:RE:If no FE announcement by SundayI suppose people read what they want to read.

1- No have definitely not sold my ALL my shares. Been with ATE since the .08c purchases. So im greener than weed.
2-Nothing wrong with taking some profit. which I have done. Thats called smart investing.
3-by me actually informing people how binomal biotech behave they make better decisions and are likely to revisit i.e. stay long, with the stock, rather than play it as a pump and dump
4- I have always backed my hypotheses with evidence. Even when discussing the clinics I posted the which clinics and the numbers so others can verify. 
5- Given the way you asked the question, I will buy back in when I do....I dont present pearls before swine. 


Kipawarocks15 wrote: So it's safe to say that you have sold all of your ATE holdings based on the impending pullback. Why are you still here with the "die hards...dopes...unrealistic dreamers ...and investing rubes"? At what point are you going to buy back in ? 


Bullboard Posts